Language

English

Publication Date

4-19-2023

Journal

Science Translational Medicine

DOI

10.1126/scitranslmed.adf4086

PMID

37075130

PMCID

PMC10676743

PubMedCentral® Posted Date

11-26-2023

PubMedCentral® Full Text Version

Author MSS

Abstract

Glutaric aciduria type I (GA-1) is an inborn error of metabolism with a severe neurological phenotype caused by the deficiency of glutaryl-coenzyme A dehydrogenase (GCDH), the last enzyme of lysine catabolism. Current literature suggests that toxic catabolites in the brain are produced locally and do not cross the blood-brain barrier. In a series of experiments using knockout mice of the lysine catabolic pathway and liver cell transplantation, we uncovered that toxic GA-1 catabolites in the brain originated from the liver. Moreover, the characteristic brain and lethal phenotype of the GA-1 mouse model was rescued by two different liver-directed gene therapy approaches: Using an adeno-associated virus, we replaced the defective

Keywords

Glutaryl-CoA Dehydrogenase, Lysine, Mice, Knockout, Amino Acid Metabolism, Inborn Errors, Brain Diseases, Metabolic, Liver, Mice, Animals

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.